AzTrials
AzTrials

Health Risk BehaviorsMetaYouthNCT05332886

Metaverse-Based Healthy Life Program for Youth

A study testing MetaHealth Group and MobileHealth Group in people with Health Risk Behaviors and Healthy Lifestyle, run by Ayşegül İşler Dalgıç at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study was planned within the scope of the call titled "Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD)" with identity number HORIZON-HLTH-2022-DISEASE-07-03. Read more about this study

Who is it for?
Ages 15 to 24 yearsHealthy volunteers can take part
What is being tested?
MetaHealth Group and MobileHealth Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
600 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jul 2024to 1 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 24 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Being a university student in the project partner countries and not older than 24,
  • Having a score of 130 or lower on the HLBS II in the first stage of the research,
  • Determining that BMI ≥ 25-34.99 kg/m2 in the first stage of the research and
  • Using a smartwatch during the research,
  • Accepting to participate in the research voluntarily

Who cannot join

  • Having chronic diseases (asthma, diabetes, heart, kidney failure, hypertension, cancer, etc.)
  • Those who have a drug that they use constantly
  • Having a psychiatric diagnosis (depression, anxiety, bipolar disorder, schizophrenia, etc.)
  • Having a disease that prevents the use of metaverse (vertigo, vision, hearing, etc.)

Trial locations and contacts

1 site in 1 country.

Ayşegül ISLER DALGIC, Professor contact

+90 242 310 6103 ext. 6124

aisler@akdeniz.edu.tr

Turkey (Türkiye)1 site
  • Aysegul ISLER DALGIC

    Antalya, Konyaaltı, 07058

    Aysegul ISLER DALGIC, Prof. Dr., +90 242 310 6103 ext. 6124, aisler@akdeniz.edu.tr

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Metaverse-Based Healthy Life Program on Risk Reduction of Non-Communicable Diseases in Youth

This study was planned within the scope of the call titled "Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD)" with identity number HORIZON-HLTH-2022-DISEASE-07-03. The purpose of this project; is to determine the effect of the Metaverse-Based Healthy Life Program to be developed in the project to support youths in decreasing future risks of developing non-communicable diseases (NCDs) and in gaining healthy lifestyle behaviors (HLBs).

Read the detailed description

The project consists of three phases. Phase 1 Testing the content, quality, reliability, and usability of the "Metaverse-Based Healthy Life Program for Youth" to be developed within the scope of the project Phase 2 Identifying youth at high risk of chronic non-communicable diseases in the research population Phase 3 Evaluating the effect of "Metaverse-Based Healthy Life Program for Youth" implementation on inculcating healthy lifestyle behaviors in youth

Being tested
MetaHealth Group, MobileHealth Group
Medical subject headings
Health Risk Behaviors, Noncommunicable Diseases, Health Behavior, Sedentary Behavior, Stress, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MetaHealth GroupBehavioural

    Three metaverse rooms will be created via metaverse technology that aims to develop healthy nutrition, physical activity, and psychological resilience skills to reduce the risk of of NCDs in youth.

  • MobileHealth GroupBehavioural

    The intervention aims to develop healthy nutrition, physical activity, and psychological resilience skills using mobile application materials to reduce the risk of NCDs in youth.

Study groups in NCT05332886
Study groupRoleWhat they receive
MetaHealth GroupExperimentalIt is intervention group that aims to provide youth with healthy lifestyle behaviors by using metaverse technology.
Receives: Behavioral: MetaHealth Group
MobileHealth GroupActive comparatorIt is comparator group that aims to provide youth with healthy lifestyle behaviors by using mobile application materials with digital health education will be given to the MobileHealth Group.
Receives: Behavioral: MobileHealth Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Healthy Lifestyle Behavior Scale II (HLBS II)

    The HLBS II consists of 52 items in total and has 6 sub-factors. Sub-factors are spiritual growth, health responsibility, physical activity, nutrition, interpersonal relationships, and stress management. All items on the scale are positive. The rating is in the form of a 4-point Likert. Never (1), sometimes (2), often (3), regularly (4). The lowest score for the whole scale is 52, and the highest score is 208. The Cronbach Alpha reliability coefficient of the scale is 0.94.

    Measured: The HLBS II score will evaluate at baseline

  2. Healthy Lifestyle Behavior Scale II (HLBS II)

    The HLBS II consists of 52 items in total and has 6 sub-factors. Sub-factors are spiritual growth, health responsibility, physical activity, nutrition, interpersonal relationships, and stress management. All items on the scale are positive. The rating is in the form of a 4-point Likert. Never (1), sometimes (2), often (3), regularly (4). The lowest score for the whole scale is 52, and the highest score is 208. The Cronbach Alpha reliability coefficient of the scale is 0.94.

    Measured: The HLBS II score will evaluate at third month

  3. Healthy Lifestyle Behavior Scale II (HLBS II)

    The HLBS II consists of 52 items in total and has 6 sub-factors. Sub-factors are spiritual growth, health responsibility, physical activity, nutrition, interpersonal relationships, and stress management. All items on the scale are positive. The rating is in the form of a 4-point Likert. Never (1), sometimes (2), often (3), regularly (4). The lowest score for the whole scale is 52, and the highest score is 208. The Cronbach Alpha reliability coefficient of the scale is 0.94.

    Measured: The HLBS II score will evaluate at sixth month

  4. International Physical Activity Questionnaire-Short Form (IPAQ-SF)

    The IPAQ-SF is a standardized questionnaire prepared to measure the physical activity of people between the ages of 15 and 65. In the survey, there are 7 questions in total in 4 separate sections about the activities that have been done for a minimum of 10 minutes in the last 7 days. The results obtained in the assessment are calculated as metabolic equivalent task (MET) - min/week.

    Measured: The IPAQ-SF score will evaluate at baseline

  5. International Physical Activity Questionnaire-Short Form (IPAQ-SF)

    The IPAQ-SF is a standardized questionnaire prepared to measure the physical activity of people between the ages of 15 and 65. In the survey, there are 7 questions in total in 4 separate sections about the activities that have been done for a minimum of 10 minutes in the last 7 days. The results obtained in the assessment are calculated as metabolic equivalent task (MET) - min/week.

    Measured: The IPAQ-SF score will evaluate at third month

  6. International Physical Activity Questionnaire-Short Form (IPAQ-SF)

    The IPAQ-SF is a standardized questionnaire prepared to measure the physical activity of people between the ages of 15 and 65. In the survey, there are 7 questions in total in 4 separate sections about the activities that have been done for a minimum of 10 minutes in the last 7 days. The results obtained in the assessment are calculated as metabolic equivalent task (MET) - min/week.

    Measured: The IPAQ-SF score will evaluate at sixth month

  7. Positive and Negative Affect Schedule (PANAS-SF)

    The PANAS-SF is a self-report questionnaire that consists of two 10-item scales to measure both positive and negative affect. Each item is rated on a 5-point scale of 1 (not at all) to 5 (very much).

    Measured: The PANAS-SF score will evaluate at baseline

  8. Positive and Negative Affect Schedule (PANAS-SF)

    The PANAS-SF is a self-report questionnaire that consists of two 10-item scales to measure both positive and negative affect. Each item is rated on a 5-point scale of 1 (not at all) to 5 (very much).

    Measured: The PANAS-SF score will evaluate at third month

  9. Positive and Negative Affect Schedule (PANAS-SF)

    The PANAS-SF is a self-report questionnaire that consists of two 10-item scales to measure both positive and negative affect. Each item is rated on a 5-point scale of 1 (not at all) to 5 (very much).

    Measured: The PANAS-SF score will evaluate at sixth month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2022
  2. Study start1 Jul 2024 (estimated)
  3. Primary completion1 Mar 2025 (estimated)
  4. Study completion1 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel Desing Active Comparative Group Randomized Controlled Trial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05332886
Sponsor's protocol ID
123456789
Acronym
MetaYouth
Status last verified
Apr 2022
First submitted
24 Mar 2022
Last updated
18 Apr 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: It has been decided not to share data within the scope of the General Data Protection Regulation.

Questions about this trial

What is this clinical trial studying?

A study testing MetaHealth Group and MobileHealth Group in people with Health Risk Behaviors and Healthy Lifestyle, run by Ayşegül İşler Dalgıç at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ayşegül ISLER DALGIC, Professor (+90 242 310 6103 ext. 6124, aisler@akdeniz.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Healthy Lifestyle Behavior Scale II (HLBS II) (time frame: The HLBS II score will evaluate at baseline). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in